These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Haloperidol and sudden death due to pulmonary edema. Mahutte CK; Nakasato SK; Light RW Arch Intern Med; 1982 Oct; 142(10):1951-2. PubMed ID: 7125780 [No Abstract] [Full Text] [Related]
6. [Sudden death following a single oral administration of haloperidol]. Vorel-Havelkova E; Brombacher PJ Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1301; author reply 1302. PubMed ID: 12138682 [No Abstract] [Full Text] [Related]
7. Clinical experience with low doses of haloperidol in the treatment of neuroses. Preiningerová O; Zapletálek M; Kudrnová K; Svejkovská J Act Nerv Super (Praha); 1979 Oct; 21(3):136. PubMed ID: 517076 [No Abstract] [Full Text] [Related]
8. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843 [TBL] [Abstract][Full Text] [Related]
9. Haloperidol (Haldol) and possible association with fatal sickle cell disease (Hgb S-C). Stilwell AD Am J Forensic Med Pathol; 1984 Sep; 5(3):286-7. PubMed ID: 6496445 [No Abstract] [Full Text] [Related]
10. Haloperidol: the danger of cardiotoxic effects? Ketai R; Mozdzen JJ; Matthews J Am J Psychiatry; 1981 Sep; 138(9):1259-60. PubMed ID: 7270742 [No Abstract] [Full Text] [Related]
11. [Sudden death following a single oral administration of haloperidol]. Remijnse PL; Eeckhout AM; van Guldener C Ned Tijdschr Geneeskd; 2002 Apr; 146(16):768-71. PubMed ID: 11998355 [TBL] [Abstract][Full Text] [Related]
12. Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. Flaherty JA; Lahmeyer HW Am J Psychiatry; 1978 Nov; 135(11):1414-5. PubMed ID: 707650 [No Abstract] [Full Text] [Related]
17. [Administration of high dose haloperidol in a patient refractory to treatment with traditional and atypical neuroleptics]. Stip E; Bruneau MA Encephale; 1996; 22(4):298-300. PubMed ID: 9035986 [No Abstract] [Full Text] [Related]
18. Haloperidol: therapeutic window in schizophrenia. Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684 [TBL] [Abstract][Full Text] [Related]
19. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study. McEvoy JP; Stiller RL; Farr R J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363 [TBL] [Abstract][Full Text] [Related]